U01CA224044
Cooperative Agreement
Overview
Grant Description
Patient-derived models of prostate cancer for personalized medicine.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Texas
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 393% from $1,041,019 to $5,129,971.
The Univeristy Of Texas M.D. Anderson Cancer Center was awarded
Patient-Derived Models of Prostate Cancer for Personalized Medicine
Cooperative Agreement U01CA224044
worth $5,129,971
from National Cancer Institute in August 2019 with work to be completed primarily in Texas United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.396 Cancer Biology Research.
The Cooperative Agreement was awarded through grant opportunity Biological Comparisons in Patient-Derived Models of Cancer (U01).
Status
(Complete)
Last Modified 6/20/24
Period of Performance
8/1/19
Start Date
7/31/24
End Date
Funding Split
$5.1M
Federal Obligation
$0.0
Non-Federal Obligation
$5.1M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U01CA224044
Transaction History
Modifications to U01CA224044
Additional Detail
Award ID FAIN
U01CA224044
SAI Number
U01CA224044-483899171
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Awardee UEI
S3GMKS8ELA16
Awardee CAGE
0KD38
Performance District
TX-90
Senators
John Cornyn
Ted Cruz
Ted Cruz
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) | Health research and training | Grants, subsidies, and contributions (41.0) | $5,144,971 | 100% |
Modified: 6/20/24